These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 14705934)

  • 1. Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase catalytic subunit.
    Akamine P; Madhusudan ; Brunton LL; Ou HD; Canaves JM; Xuong NH; Taylor SS
    Biochemistry; 2004 Jan; 43(1):85-96. PubMed ID: 14705934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular design and biological activity of potent and selective protein kinase inhibitors related to balanol.
    Koide K; Bunnage ME; Gomez Paloma L; Kanter JR; Taylor SS; Brunton LL; Nicolaou KC
    Chem Biol; 1995 Sep; 2(9):601-8. PubMed ID: 9383464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases.
    Hardianto A; Yusuf M; Liu F; Ranganathan S
    BMC Bioinformatics; 2017 Dec; 18(Suppl 16):572. PubMed ID: 29297286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential and selective inhibition of protein kinase A and protein kinase C in intact cells by balanol congeners.
    Gustafsson AB; Brunton LL
    Mol Pharmacol; 1999 Aug; 56(2):377-82. PubMed ID: 10419557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational analysis of PKA-balanol interactions.
    Wong CF; Hünenberger PH; Akamine P; Narayana N; Diller T; McCammon JA; Taylor S; Xuong NH
    J Med Chem; 2001 May; 44(10):1530-9. PubMed ID: 11334563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for selective inhibition of human PKG Iα by the balanol-like compound N46.
    Qin L; Sankaran B; Aminzai S; Casteel DE; Kim C
    J Biol Chem; 2018 Jul; 293(28):10985-10992. PubMed ID: 29769318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic features of cAMP-dependent protein kinase revealed by apoenzyme crystal structure.
    Akamine P; Madhusudan ; Wu J; Xuong NH; Ten Eyck LF; Taylor SS
    J Mol Biol; 2003 Mar; 327(1):159-71. PubMed ID: 12614615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and protein kinase inhibitory activity of balanol analogues with modified benzophenone subunits.
    Lampe JW; Biggers CK; Defauw JM; Foglesong RJ; Hall SE; Heerding JM; Hollinshead SP; Hu H; Hughes PF; Jagdmann GE; Johnson MG; Lai YS; Lowden CT; Lynch MP; Mendoza JS; Murphy MM; Wilson JW; Ballas LM; Carter K; Darges JW; Davis JE; Hubbard FR; Stamper ML
    J Med Chem; 2002 Jun; 45(12):2624-43. PubMed ID: 12036372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP.
    Wu J; Jones JM; Nguyen-Huu X; Ten Eyck LF; Taylor SS
    Biochemistry; 2004 Jun; 43(21):6620-9. PubMed ID: 15157095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase.
    Narayana N; Diller TC; Koide K; Bunnage ME; Nicolaou KC; Brunton LL; Xuong NH; Ten Eyck LF; Taylor SS
    Biochemistry; 1999 Feb; 38(8):2367-76. PubMed ID: 10029530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine.
    Narayana N; Cox S; Shaltiel S; Taylor SS; Xuong N
    Biochemistry; 1997 Apr; 36(15):4438-48. PubMed ID: 9109651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Protein kinase inhibitor balanol: structure-activity relationships and structure-based computational studies.
    Pande V; Ramos MJ; Gago F
    Anticancer Agents Med Chem; 2008 Aug; 8(6):638-45. PubMed ID: 18690827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverse dynamics features of novel protein kinase C (PKC) isozymes determine the selectivity of a fluorinated balanol analogue for PKCε.
    Hardianto A; Khanna V; Liu F; Ranganathan S
    BMC Bioinformatics; 2019 Feb; 19(Suppl 13):342. PubMed ID: 30717648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of protein kinases by balanol: specificity within the serine/threonine protein kinase subfamily.
    Setyawan J; Koide K; Diller TC; Bunnage ME; Taylor SS; Nicolaou KC; Brunton LL
    Mol Pharmacol; 1999 Aug; 56(2):370-6. PubMed ID: 10419556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR backbone assignment of a protein kinase catalytic domain by a combination of several approaches: application to the catalytic subunit of cAMP-dependent protein kinase.
    Langer T; Vogtherr M; Elshorst B; Betz M; Schieborr U; Saxena K; Schwalbe H
    Chembiochem; 2004 Nov; 5(11):1508-16. PubMed ID: 15481030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of human G protein-coupled receptor kinase 2 in complex with the kinase inhibitor balanol.
    Tesmer JJ; Tesmer VM; Lodowski DT; Steinhagen H; Huber J
    J Med Chem; 2010 Feb; 53(4):1867-70. PubMed ID: 20128603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of a complex between the catalytic and regulatory (RIalpha) subunits of PKA.
    Kim C; Xuong NH; Taylor SS
    Science; 2005 Feb; 307(5710):690-6. PubMed ID: 15692043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and protein kinase C inhibitory activities of acyclic balanol analogs that are highly selective for protein kinase C over protein kinase A.
    Defauw JM; Murphy MM; Jagdmann GE; Hu H; Lampe JW; Hollinshead SP; Mitchell TJ; Crane HM; Heerding JM; Mendoza JS; Davis JE; Darges JW; Hubbard FR; Hall SE
    J Med Chem; 1996 Dec; 39(26):5215-27. PubMed ID: 8978850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of ligand binding to cAMP-dependent protein kinase.
    Hünenberger PH; Helms V; Narayana N; Taylor SS; McCammon JA
    Biochemistry; 1999 Feb; 38(8):2358-66. PubMed ID: 10029529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing cAMP-dependent protein kinase holoenzyme complexes I alpha and II beta by FT-IR and chemical protein footprinting.
    Yu S; Mei FC; Lee JC; Cheng X
    Biochemistry; 2004 Feb; 43(7):1908-20. PubMed ID: 14967031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.